Arcellx (ACLX)

• Market cap: $4.63B
• 1 day: -2.58%
• 5 days: -10.43%
• 1 month: 6.64%
• 3 months: 22.21%
• 6 months: 32.15%
• Year to date: 5.92%
• 1 year: -7.79%
• 5 years: 396.49%
• 10 years: 396.49%
• Sector: Healthcare
• Industry: Biotechnology

About: Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Employees: 163